试用GDP值、人均可支配收入分析糖尿病患者“看病贵”问题  

Analysis on High Cost to Access Medical Service for Diabetic Patients according to GDP and Per-captia Disposable Income

作　　者：李荣凌[1] 张洪[1] 宋金春[1] 

机构地区：[1]武汉大学人民医院,武汉市430060

出　　处：《中国药房》2010年第25期2307-2310,共4页China Pharmacy

摘　　要：目的:为正确认识糖尿病患者"看病贵"问题,控制医疗费用增长提供参考数据。方法:比较1998年与2008年我院糖尿病药日均药费,并与国内生产总值(GDP)、人均可支配收入进行对比。结果:2008年同1998年相比,GDP、人均可支配收入、药品销售总额、糖尿病药销售额分别是3.78、3.11、3.87、2.73倍;胰岛素注射剂使用量及日均费用分别是3.46、1.23倍;口服降糖药DDDs及日均费用分别是1.69、1.41倍;胰岛素注射剂和口服降糖药日均费用增长率均低于人均可支配收入增长率;日均费用增加主要是由于合资进口药和新药使用增多及糖尿病患者增多。结论:事实上糖尿病药日均费用增幅低于人均可支配收入增幅,因此糖尿病患者"看病贵"不等同于"药品贵",其涉及多种因素,应从全社会角度来考虑这个问题。OBJECTIVE：To provide reference data for well understanding of high cost to access medical service for diabetic patients and controlling increase of medical costs.METHODS：Average daily cost of diabetic drugs in 1998 was compared with in 2008.At the same time it was compared with GDP and per-captia disposable income（PCDI）.RESULTS：GDP,PCDI,consumption sum of total drugs and consumption sum of diabetic drugs in 2008 respectively were 3.78 times,3.11 times,3.87 times,2.73 times compared with in 1998.Amount of and daily average expenses of insulin respectively were 3.46 times,1.23 times;DDDs and daily average expense of oral hypoglycemics respectively were 1.69 times,1.41 times,compared with in 1998.Incremental rate of daily average expense of insulin injection and oral hypoglycemics were lower than that of PCDI.The daily average expense was increased as a result of the use of joint venture import drugs and new drugs and increase of diabetic patients.CONCLUSION：Incremental rate of daily average expense of diabetic drugs is lower than that of PCDI.High cost to access medical service for diabetic patients isn＇t equal to high cost of drugs.Many factors related should be considered from the point of view of society.

关 键 词：糖尿病 GDP 人均可支配收入 看病贵 

分 类 号：R95[医药卫生—药学]